19-40800591-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The ENST00000303961.9(EGLN2):ā€‹c.19C>Gā€‹(p.Pro7Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000688 in 1,453,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P7L) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 6.9e-7 ( 0 hom. )

Consequence

EGLN2
ENST00000303961.9 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.12
Variant links:
Genes affected
EGLN2 (HGNC:14660): (egl-9 family hypoxia inducible factor 2) The hypoxia inducible factor (HIF) is a transcriptional complex that is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. This gene encodes an enzyme responsible for this post-translational modification. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream RAB4B (RAB4B, member RAS oncogene family) gene. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.066019416).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EGLN2NM_080732.4 linkuse as main transcriptc.19C>G p.Pro7Ala missense_variant 2/6 ENST00000303961.9 NP_542770.2
RAB4B-EGLN2NR_037791.1 linkuse as main transcriptn.1067C>G non_coding_transcript_exon_variant 8/12
EGLN2NM_053046.4 linkuse as main transcriptc.19C>G p.Pro7Ala missense_variant 2/6 NP_444274.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EGLN2ENST00000303961.9 linkuse as main transcriptc.19C>G p.Pro7Ala missense_variant 2/61 NM_080732.4 ENSP00000307080 P1Q96KS0-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.88e-7
AC:
1
AN:
1453060
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
721890
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.03e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 22, 2022The p.P7A variant (also known as c.19C>G), located in coding exon 1 of the EGLN2 gene, results from a C to G substitution at nucleotide position 19. The proline at codon 7 is replaced by alanine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
20
DANN
Benign
0.78
DEOGEN2
Benign
0.26
.;T;T;T;T;.;.;.;.;.
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.71
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.74
T;.;T;.;T;T;T;T;T;T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.066
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
.;N;.;N;N;.;.;.;.;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.20
.;N;.;N;.;.;.;.;.;.
REVEL
Benign
0.095
Sift
Uncertain
0.0080
.;D;.;D;.;.;.;.;.;.
Sift4G
Benign
0.16
T;T;T;T;T;D;D;T;D;T
Polyphen
0.36
.;B;.;B;B;.;.;.;.;.
Vest4
0.26, 0.27, 0.22
MutPred
0.090
Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);
MVP
0.29
MPC
0.55
ClinPred
0.49
T
GERP RS
0.61
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.030
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr19-41306496; API